A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer
Clinical trial NCT02066961 · COMPLETED
Trial details
- NCT number
- NCT02066961
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2013-12-31
- Primary completion
- 2019-11-14
- Enrollment
- 1533
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.